STAT3_RAT - dbPTM
STAT3_RAT - PTM Information in dbPTM
Basic Information of Protein
UniProt ID STAT3_RAT
UniProt AC P52631
Protein Name Signal transducer and activator of transcription 3
Gene Name Stat3
Organism Rattus norvegicus (Rat).
Sequence Length 770
Subcellular Localization Cytoplasm. Nucleus. Shuttles between the nucleus and the cytoplasm. Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4. Constitutive nuclear presence is ind
Protein Description Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors. Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. Binds to the interleukin-6 (IL-6)-responsive elements identified in the promoters of various acute-phase protein genes. Activated by IL31 through IL31RA. Acts as a regulator of inflammatory response by regulating differentiation of naive CD4(+) T-cells into T-helper Th17 or regulatory T-cells (Treg): deacetylation and oxidation of lysine residues by LOXL3, leads to disrupt STAT3 dimerization and inhibit its transcription activity. Involved in cell cycle regulation by inducing the expression of key genes for the progression from G1 to S phase, such as CCND1 (By similarity). Mediates the effects of LEP on melanocortin production, body energy homeostasis and lactation (By similarity). May play an apoptotic role by transctivating BIRC5 expression under LEP activation. Cytoplasmic STAT3 represses macroautophagy by inhibiting EIF2AK2/PKR activity (By similarity). Plays a crucial role in basal beta cell functions, such as regulation of insulin secretion (By similarity)..
Protein Sequence MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPMEIARIVARCLWEESRLLQTAATAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVDLFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEADPGSAAPYLKTKFICVTPTTCSNTIDLPMSPRTLDSLMQFGNNGEGAEPSAGGQFESLTFDMDLTSECATSPM
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAQWNQLQQ
------CCCHHHHHH
24.09-
94PhosphorylationKQFLQSRYLEKPMEI
HHHHHHCCCCCHHHH
25.1822276854
268PhosphorylationDRLENWITSLAESQL
HHHHHHHHHHHHHHH
14.8717683130
269PhosphorylationRLENWITSLAESQLQ
HHHHHHHHHHHHHHH
19.2217683130
273PhosphorylationWITSLAESQLQTRQQ
HHHHHHHHHHHHHHH
30.5017683130
383AcetylationAALRGSRKFNILGTN
EHHCCCCCEEEECCC
44.4522902405
539PhosphorylationLLGPGVNYSGCQITW
HHCCCCCCCCCEEEE
12.2022276854
601AcetylationERAILSTKPPGTFLL
HHHHHCCCCCCEEEE
45.93-
601DeaminationERAILSTKPPGTFLL
HHHHHCCCCCCEEEE
45.93-
615AcetylationLRFSESSKEGGVTFT
EEEECCCCCCCEEEE
70.43-
615DeaminationLRFSESSKEGGVTFT
EEEECCCCCCCEEEE
70.43-
631AcetylationVEKDISGKTQIQSVE
EEECCCCCEEEEECC
30.39-
631DeaminationVEKDISGKTQIQSVE
EEECCCCCEEEEECC
30.39-
685AcetylationPKEEAFGKYCRPESQ
CHHHHCCCCCCHHHC
34.42-
685DeaminationPKEEAFGKYCRPESQ
CHHHHCCCCCCHHHC
34.42-
686PhosphorylationKEEAFGKYCRPESQE
HHHHCCCCCCHHHCC
8.2825575281
691PhosphorylationGKYCRPESQEHPEAD
CCCCCHHHCCCCCCC
43.4825575281
701PhosphorylationHPEADPGSAAPYLKT
CCCCCCCCCCCCCCE
27.0123984901
705PhosphorylationDPGSAAPYLKTKFIC
CCCCCCCCCCEEEEE
18.9920222050
707AcetylationGSAAPYLKTKFICVT
CCCCCCCCEEEEEEC
43.77-
708PhosphorylationSAAPYLKTKFICVTP
CCCCCCCEEEEEECC
28.7025575281
714PhosphorylationKTKFICVTPTTCSNT
CEEEEEECCCCCCCC
15.5427097102
716PhosphorylationKFICVTPTTCSNTID
EEEEECCCCCCCCCC
30.9427097102
717PhosphorylationFICVTPTTCSNTIDL
EEEECCCCCCCCCCC
18.3627097102
719PhosphorylationCVTPTTCSNTIDLPM
EECCCCCCCCCCCCC
34.6127097102
721PhosphorylationTPTTCSNTIDLPMSP
CCCCCCCCCCCCCCH
10.2827097102
727PhosphorylationNTIDLPMSPRTLDSL
CCCCCCCCHHHHHHH
14.8615659221

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
705YPhosphorylationKinaseFERP09760
Uniprot
705YPhosphorylationKinaseFGRQ6P6U0
GPS
705YPhosphorylationKinaseFYNQ62844
GPS
705YPhosphorylationKinaseHCKP50545
GPS
705YPhosphorylationKinaseSRCQ9WUD9
GPS
705YPhosphorylationKinasePTK6-Uniprot
727SPhosphorylationKinaseDAPK3O88764
Uniprot
727SPhosphorylationKinasePRKCEP09216
Uniprot
727SPhosphorylationKinaseNEK6P59895
Uniprot
727SPhosphorylationKinaseNLKD3ZSZ3
Uniprot
727SPhosphorylationKinaseDYRK2-Uniprot
727SPhosphorylationKinaseIRAK1-Uniprot
727SPhosphorylationKinaseRPS6KA5-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
727SPhosphorylation

-

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of STAT3_RAT !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PDIA3_RATPdia3physical
10464281

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of STAT3_RAT

loading...

Related Literatures of Post-Translational Modification

TOP